Revenues grew 12% YoY to | 533 crore (I-direct estimate: | 578 crore) on the back of 15% growth in domestic sales to | 154 crore (Idirect estimate: | 157 crore). Export formulations grew 9% YoY to | 361 crore (I-direct estimate: | 408 crore). The sharp growth in the US was largely offset by the decline in Asia EBITDA margins declined 100 bps YoY to 33.4% (I-direct estimate: 35.0%) mainly due to higher other expenditure Net profit increased 25% YoY to | 143 crore (I-direct estimate: | 145 crore) mainly due to forex gain of | 10 crore and lower taxation...